Routine: SRTPUTL4

Package	Total	Caller Graph
Surgery	1	SRTPUTLC

Entry Points

Name	Comments	DBIA/ICR reference
TR
GET
C	;;3^VACO ID
D	;;4^Recipient Height^
E	;;5^Recipient Weight^
I	;;9^IVIG Recipient^
AJ	;;10^Recipient ABO Blood Type^
AA	;;11^Date Placed on Waiting List^
AB	;;12^Recipient CMV^
AC	;;13^Recipient HLA-A Typing^
AD	;;14^Recipient HLA-B Typing^
AE	;;15^Recipient HLA-C Typing^
AF	;;16^Recipient HLA-BW Typing^
AG	;;17^Recipient HLA-DR Typing^
AH	;;18^Recipient HLA-DQ Typing^
AI	;;19^Transplant Comments^
BJ	;;20^Acetaminophen Toxicity^
BA	;;21^Acute Liver Failure^
BB	;;22^Lung Cancer^
BC	;;23^Alcoholic Cirrhosis^
BD	;;24^Alpha 1 Anti-Trypsin Deficiency^
BE	;;25^Bronchiectasis^
BF	;;26^Glomerular Sclerosis/Nephritis^
BG	;;27^Graft Failure^
BH	;;28^HBV Cirrhosis (Hepatitis B)^
BI	;;29^HCC (Hepatocellular CA)^
CJ	;;30^HCV Cirrhosis (Hepatitis C)^
CA	;;31^Donor Height^
CB	;;32^Interstitial Lung Disease^
CC	;;33^Membranous Nephropathy^
CD	;;34^Metabolic^
CE	;;35^NASH ^
CF	;;36^Donor Weight^
CG	;;37^Polycystic Disease^
CH	;;38^Primary Biliary Cholangitis^
CI	;;39^Primary Sclerosing Cholangitis^
DJ	;;40^Pulmonary Fibrosis^
DA	;;41^Pulmonary Hypertension^
DB	;;42^Renal Cancer^
DC	;;43^Sarcoidosis^
DD	;;44^Donor Race^
DE	;;45^Donor Gender^
DF	;;46^Donor Age^
DG	;;47^Biliary Stricture^
DH	;;48^Donor ABO Blood Type^
DI	;;49^Donor CMV^
EJ	;;50^LAS Score at Listing^
EA	;;51^LAS Score at Transplant^
EB	;;52^MELD Score at Listing^
EC	;;53^Biologic MELD score at listing^
ED	;;54^MELD score at transplant^
EE	;;55^Biologic MELD score at transplant^
EF	;;56^Bile Leak^
EG	;;57^UNOS Status at time of Transplant^
EH	;;58^UNOS Status at time of Listing^
EI	;;59^Diabetic Retinopathy^
FJ	;;60^Diabetic Neuropathy^
FA	;;61^Cardiac Disease (CAD, AF, EF<50%)^
FB	;;62^Inotrope Dependent Pre-Transplant^
FC	;;63^Medical Center Division^
FD	;;64^Donor HLA-A Typing^
FE	;;65^Donor HLA-B Typing^
FF	;;66^Donor HLA-C Typing^
FG	;;67^Donor HLA-BW Typing^
FH	;;68^Crossmatch D/R^
FI	;;69^Deceased Donor^
GJ	;;70^Donor Date of Birth^
GA	;;71^Elevated PAP^
GB	;;72^Donor HLA-DQ Typing^
GC	;;73^Donor HLA-DR Typing^
GD	;;74^Pulmonary Hypertension / Elevated PAP^
GE	;;75^Liver Disease^
GF	;;76^COPD ^
GG	;;77^Donor Substance Abuse^
GH	;;78^Porto Pulmonary Hypertension^
GI	;;79^History of Bleeding Esophageal and/or Gastric Varices^
HJ	;;80^Pre-Transplant Malignancy^
HA	;;81^History of Preop Transplant Skin Malignancy^
HB	;;82^History of Other Pre-Transplant Malignancy^
HC	;;83^Recipient Substance Abuse^
HD	;;84^Active Infection for PSC^
HE	;;85^Warm Ischemia Time For Organ^
HF	;;86^Acute or Chronic Encephalopathy^
HG	;;87^Cold Ischemia Time for Organ^
HH	;;88^History of Ascites^
HI	;;89^Total Ischemia Time for Organ^
IJ	;;90^Non-Compliance (Med and Diet)^
IA	;;91^On Methadone^
IB	;;92^Post Transplant Prophylaxis for TB/Antimycobacterial Treatment^
ID	;;94^Rejection^
IE	;;95^IgA Nephropathy^
IF	;;96^Calcineurin Inhibitor Toxicity^
IG	;;97^Lithium Toxicity^
IH	;;98^Obstructive Uropathy from BPH^
II	;;99^Autoimmune Hepatitis^
AJJ	;;100^Cryptogenic Cirrhosis^
AJA	;;101^Chronic Rejection^
AJB	;;102^Hepatic Artery Thrombosis^
AJC	;;103^Living Donor^
AJD	;;104^Donor with Malignancy^
AJE	;;105^Primary Non-Function^
AJF	;;106^Secondary Sclerosing Cholangitis^
AJG	;;107^Toxic Exposure^
AJH	;;108^HIV + (positive)^
AJI	;;109^Post Transplant Prophylaxis for CMV/Antiviral Treatment^
AAJ	;;110^Post Transplant Prophylaxis for PCP/Antibacterial Treatment^
AAA	;;111^Portal Vein Thrombosis^
AAB	;;112^Other Cardiomyopathy^
AAC	;;113^Lung Disease^
AAD	;;114^Renal Impairment (Serum Creatinine >1.5)^
AAE	;;115^Active Infection Requiring Antibiotics^
AAF	;;116^Bleeding/Transfusions^
AAG	;;117^Pneumonia^
AAH	;;118^On Ventilator > 48 Hours^
AAI	;;119^Cardiac Arrest Requiring CPR^
ABJ	;;120^Psychosis^
ABA	;;121^Stroke/CVA^
ABB	;;122^Coma Greater than 24 Hours Postop (Y/N)^
ABC	;;123^Superficial Incisional SSI^
ABD	;;124^Deep Incisional SSI^
ABE	;;125^Systemic Sepsis^
ABF	;;126^Return to Surgery within 30 days^
ABG	;;127^Seizures^
ABH	;;128^Emphysema^
ABI	;;129^Other Diagnosis^
ACJ	;;130^New Mechanical Circulatory Support^
ACA	;;131^Preop Functional Health Status^
ACB	;;132^Peripheral Vascular Disease^
ACC	;;133^Graft Failure Date^
ACD	;;134^Pancreas^
ACE	;;135^Glucose at Time of Listing^
ACF	;;136^C-peptide at Time of Listing^
ACG	;;137^Pancreatic Duct Anastomosis^
ACH	;;138^Glucose Post Transplant^
ACI	;;139^Amylase Post Transplant^
ADJ	;;140^Lipase Post Transplant^
ADA	;;141^Insulin Required Post transplant^
ADB	;;142^Oral Hypoglycemics Required Post Transplant^
ADC	;;143^PRA at Listing^
ADD	;;144^PRA at Transplant^
ADE	;;145^Hypertension Requiring Meds^
ADF	;;146^Transfusion >4 RBC Units^
ADH	;;148^Reoperation for Bleeding^
ADI	;;149^Amiodarone Use^
AEJ	;;150^Heparin Sensitivity^
AEA	;;151^Hyperlipidemia History^
AEB	;;152^Ventricular Tachycardia^
AEC	;;153^Prior Blood Transfusion^
AED	;;154^Creatinine on Day of Transplant^
AEE	;;155^Dilated Cardiomyopathy^
AEF	;;156^Coronary Artery Disease^
AEG	;;157^Ischemic Cardiomyopathy^
AEH	;;158^Alcoholic Cardiomyopathy^
AEI	;;159^Valvular Cardiomyopathy^
AFJ	;;160^Idiopathic Cardiomyopathy^
AFA	;;161^Viral Cardiomyopathy^
AFB	;;162^Peripartum Cardiomyopathy^
AFC	;;163^PVR Before Vasodilation^
AFD	;;164^PVR After Vasodilation^
AFE	;;165^LVEF % ^
AFF	;;166^PRA %^
AFG	;;167^PA Systolic Pressure^
AFH	;;168^PAW Mean Pressure^
AFI	;;169^FEV1 ^
AGJ	;;170^Date of Death^
AGB	;;172^Prior MI^
AGC	;;173^Number of Prior Heart Surgeries^
AGE	;;175^Congestive Heart Failure (CHF)^
AGF	;;176^IV NTG within 48 Hours^
AGG	;;177^Current Digoxin Use^
AGH	;;178^Current Diuretic Use^
AGI	;;179^Preoperative Circulatory Device^
AHA	;;181^Assessment Status^
AHB	;;182^Transplant Type^
AHD	;;184^Date Transmitted^
AHE	;;185^VA or Non-VA Indicator^
AHG	;;187^Date Started Dialysis^
AHI	;;189^Tracheostomy^
AIJ	;;190^Mediastinitis^
AIA	;;191^Renal Failure Requiring Dialysis^
AIB	;;192^Perioperative MI^
AIC	;;193^Operative Death^
AIG	;;197^Plasmapheresis^
AIH	;;198^Tobacco Use^
AII	;;199^Tobacco Use Timeframe^
BJJ	;;200^Diabetes Mellitus: Chronic, Long-term Management^
BJA	;;201^Diabetes Mellitus: Management Prior to Surgery^
BJB	;;202^Prior Surgical Repair/Carotid Artery Obstruction^
BJC	;;203^History of CVD Events^

>>	Not killed explicitly
*	Changed
!	Killed
~	Newed

Name	Field # of Occurrence
>> SRDT	SRTPUTL4+5, SRTPUTL4+6, SRTPUTL4+7
>> SRFLD	SRTPUTL4+4, SRTPUTL4+5
>> SRLR(	SRTPUTL4+5*, SRTPUTL4+6
>> SRMM	SRTPUTL4+4
>> SRP	TR*
>> SRTPP	SRTPUTL4+3, SRTPUTL4+4, SRTPUTL4+5
>> SRX(	SRTPUTL4+4*, SRTPUTL4+7!
SRX1	SRTPUTL4+2~
SRXX	SRTPUTL4+2~
>> SRYY(	SRTPUTL4+3, SRTPUTL4+4, SRTPUTL4+5
>> SRZ	SRTPUTL4+3, SRTPUTL4+4, SRTPUTL4+5, SRTPUTL4+7
>> SRZ1	SRTPUTL4+4, SRTPUTL4+5, SRTPUTL4+7*, TR
SRZZ	SRTPUTL4+2~
>> X	SRTPUTL4+4, SRTPUTL4+5, GET*

Name	Field # of Occurrence
$T(@J	GET
$T(@SRP	SRTPUTL4+4, SRTPUTL4+5

Customize PDF page

Package: Surgery

Routine: SRTPUTL4

Information

Source Information

Caller Graph

Legends:

Package Component Superscript legend

Caller Graph Total: 1

Entry Points

Label References

Local Variables

Legend:

Marked Items